Alpha-1 Antitrypsin Deficiency: Home Therapy
While available in only a few countries, home therapy is a possible strategy for the treatment of alpha-1 antitrypsin deficiency. We want to describe our experience in the management of human alpha-1 antitrypsin using home care intravenous augmentation therapy during this emergency period caused by...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-04-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2021.575402/full |
id |
doaj-1a0946e1e6414b9b87b83c4beba90b98 |
---|---|
record_format |
Article |
spelling |
doaj-1a0946e1e6414b9b87b83c4beba90b982021-04-15T08:28:34ZengFrontiers Media S.A.Frontiers in Pharmacology1663-98122021-04-011210.3389/fphar.2021.575402575402Alpha-1 Antitrypsin Deficiency: Home TherapyAnna Annunziata0Maurizia Lanza1Antonietta Coppola2Paolo Andreozzi3Sara Spinelli4Giuseppe Fiorentino5Department of Respiratory Pathophysiology Monaldi Hospital, Naples, ItalyDepartment of Respiratory Pathophysiology Monaldi Hospital, Naples, ItalyDepartment of Respiratory Pathophysiology Monaldi Hospital, Naples, ItalyGastroenterology Unit, Marcianise Hospital, Caserta, ItalyDepartment of Respiratory Pathophysiology Monaldi Hospital, Naples, ItalyDepartment of Respiratory Pathophysiology Monaldi Hospital, Naples, ItalyWhile available in only a few countries, home therapy is a possible strategy for the treatment of alpha-1 antitrypsin deficiency. We want to describe our experience in the management of human alpha-1 antitrypsin using home care intravenous augmentation therapy during this emergency period caused by SARS-CoV2 infection. We assessed the safety of the home treatment and the quality of life of patients enrolled in the program.https://www.frontiersin.org/articles/10.3389/fphar.2021.575402/fullalpha-1 antitrypsin (A1AT)home therapyaugmentation therapyQOL scoreSARSCoV-2 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Anna Annunziata Maurizia Lanza Antonietta Coppola Paolo Andreozzi Sara Spinelli Giuseppe Fiorentino |
spellingShingle |
Anna Annunziata Maurizia Lanza Antonietta Coppola Paolo Andreozzi Sara Spinelli Giuseppe Fiorentino Alpha-1 Antitrypsin Deficiency: Home Therapy Frontiers in Pharmacology alpha-1 antitrypsin (A1AT) home therapy augmentation therapy QOL score SARS CoV-2 |
author_facet |
Anna Annunziata Maurizia Lanza Antonietta Coppola Paolo Andreozzi Sara Spinelli Giuseppe Fiorentino |
author_sort |
Anna Annunziata |
title |
Alpha-1 Antitrypsin Deficiency: Home Therapy |
title_short |
Alpha-1 Antitrypsin Deficiency: Home Therapy |
title_full |
Alpha-1 Antitrypsin Deficiency: Home Therapy |
title_fullStr |
Alpha-1 Antitrypsin Deficiency: Home Therapy |
title_full_unstemmed |
Alpha-1 Antitrypsin Deficiency: Home Therapy |
title_sort |
alpha-1 antitrypsin deficiency: home therapy |
publisher |
Frontiers Media S.A. |
series |
Frontiers in Pharmacology |
issn |
1663-9812 |
publishDate |
2021-04-01 |
description |
While available in only a few countries, home therapy is a possible strategy for the treatment of alpha-1 antitrypsin deficiency. We want to describe our experience in the management of human alpha-1 antitrypsin using home care intravenous augmentation therapy during this emergency period caused by SARS-CoV2 infection. We assessed the safety of the home treatment and the quality of life of patients enrolled in the program. |
topic |
alpha-1 antitrypsin (A1AT) home therapy augmentation therapy QOL score SARS CoV-2 |
url |
https://www.frontiersin.org/articles/10.3389/fphar.2021.575402/full |
work_keys_str_mv |
AT annaannunziata alpha1antitrypsindeficiencyhometherapy AT maurizialanza alpha1antitrypsindeficiencyhometherapy AT antoniettacoppola alpha1antitrypsindeficiencyhometherapy AT paoloandreozzi alpha1antitrypsindeficiencyhometherapy AT saraspinelli alpha1antitrypsindeficiencyhometherapy AT giuseppefiorentino alpha1antitrypsindeficiencyhometherapy |
_version_ |
1721526392857821184 |